Mechanistic investigations of HIV restriction by Serincs
Serincs 限制 HIV 的机制研究
基本信息
- 批准号:9927150
- 负责人:
- 金额:$ 3.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsBiologicalBiological AssayBullaCCR5 geneCell membraneCellsComplementCryo-electron tomographyCryoelectron MicroscopyDevelopmentFamilyFetusFluorescence MicroscopyFreezingHIVHIV BuddingHIV InfectionsHumanImageIndividualInfantInfectionInvestigationKineticsLeadMaternal-Fetal ExchangeMembraneMembrane FusionMembrane LipidsMembrane ProteinsModelingMolecular ConformationMothersPlacentaPlasma CellsProcessProtein IsoformsProteinsResolutionSpeedStructureTechniquesTestingTimeTissuesTomogramVertical Disease TransmissionVesicleViralVirusVirus Replicationbaseblocking factordesignfetal bloodin uteromembrane modelnovelnovel therapeuticsparticlepathogenpreventreceptortheoriestransmission process
项目摘要
PROJECT SUMMARY: The placenta forms a physical barrier to HIV transmission by
separating maternal and fetal blood and a functional barrier by expressing a plethora of
restriction factors to inhibit viral replication. However, vertical transmission of HIV does occur
in utero and shows that these defenses are imperfect. This is consistent with the recently
described viral restriction factor, Serinc, which is highly expressed in the placenta and can
incorporate into budding viral particles to inhibit their ability to infect. However, Serinc is an
imperfect restriction factor as it is inactivated by the viral accessory protein, Nef, and some
sequences of the HIV surface protein, Env. We plan to study the mechanism of how Serinc
restricts HIV infection to gain a better understanding of host-pathogen interactions
occurring in the placenta and with the hope of enabling the development of novel anti-
virals that can exploit the same viral weakness as Serinc but are not susceptible to the same
pitfalls.
Serincs are a family of 5 human plasma membrane proteins expressed in select tissues. Isoforms
Serinc3 and Serinc5 restrict HIV proliferation while Serinc2 incorporates into viral particles but does not
restrict. The exact mechanism by which Serinc3 and 5 reduce infectivity is incompletely understood but is
known to block infection at a step before cell entry. Two major theories have emerged: 1) Serinc
inactivates Env by causing changes to the conformation and distribution of Env trimers in the viral
particle or 2) Serinc slows or disrupts membrane fusion of the virus with the host cell plasma membrane.
In this study, we will take advantage of the development of plasma membrane “blebs” as a model for viral
membrane fusion to test the relative merits of two proposed mechanisms of Serinc. We will assess Serinc-
containing or -lacking HIV pseudoviruses for changes in structure and distribution of Env by cryo-
electron tomography and subtomogram averaging (aim 1). We will also assess whether Serincs block
membrane fusion by observing HIV pseudoviruses containing or lacking Serincs as they fuse to bleb
model membranes with high resolution cryo-electron tomography snapshots (aim 2.1) and higher
throughput fluorescence microscopy single-particle viral fusion assays (aim 2.2). Preliminary results
show Serinc3 and Serinc5 block membrane fusion by disrupting fusion pore opening but do not affect
Env distribution or the speed at which viral particles undergo membrane fusion. With these two aims, we
will be able to discriminate between competing hypotheses about the mechanism of Serinc restriction of
HIV infection, gain a better understanding of how HIV transmits in the placenta, and potentially enable
the development of new anti-virals.
项目总结:胎盘通过以下方式形成了HIV传播的物理屏障:
分离母体和胎儿的血液和功能屏障,
限制因子来抑制病毒复制。然而,艾滋病毒的垂直传播确实会发生
表明这些防御机制并不完善这与最近
描述了病毒限制因子Serinc,它在胎盘中高度表达,
掺入出芽的病毒颗粒中以抑制它们的感染能力。然而,Serinc是一个
不完全限制因子,因为它被病毒辅助蛋白Nef灭活,
HIV表面蛋白Env.我们计划研究Serinc
限制HIV感染,以更好地了解宿主-病原体相互作用
发生在胎盘,并希望能够开发新的抗-
可以利用与Serinc相同的病毒弱点,但对Serinc不敏感的病毒。
陷阱
丝氨酸是在选择的组织中表达的5种人质膜蛋白的家族。同种型
Serinc 3和Serinc 5限制HIV增殖,而Serinc 2掺入病毒颗粒,但不
限制。Serinc 3和Serinc 5降低感染性的确切机制尚不完全清楚,
已知在细胞进入前的一步阻断感染。出现了两种主要的理论:1)Serinc
通过引起病毒中Env三聚体的构象和分布的变化来灭活Env
或2)丝氨酸减慢或破坏病毒与宿主细胞质膜的膜融合。
在这项研究中,我们将利用质膜“水泡”的发展作为病毒的模型,
膜融合,以测试Serinc.我们将评估Serinc-
含有或缺乏HIV假病毒,通过冷冻-
电子断层扫描和亚断层图像平均(目标1)。我们还将评估Serincs是否阻止
通过观察HIV假病毒融合到疱疹时含有或缺乏丝氨酸蛋白酶的膜融合
具有高分辨率低温电子断层扫描快照(aim 2.1)和更高分辨率的模型膜
通量荧光显微镜单颗粒病毒融合测定(目标2.2)。初步结果
显示Serinc 3和Serinc 5通过破坏融合孔开放而阻断膜融合,但不影响
Env分布或病毒颗粒进行膜融合的速度。有了这两个目标,我们
将能够区分关于丝氨酸限制的机制的竞争假设,
艾滋病毒感染,更好地了解艾滋病毒如何在胎盘中传播,并可能使
开发新的抗病毒药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amanda Elizabeth Ward其他文献
Amanda Elizabeth Ward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amanda Elizabeth Ward', 18)}}的其他基金
Mechanistic investigations of HIV restriction by Serincs
Serincs 限制 HIV 的机制研究
- 批准号:
10360510 - 财政年份:2020
- 资助金额:
$ 3.41万 - 项目类别:
相似海外基金
Defining the biological boundaries to sustain extant life on Mars
定义维持火星现存生命的生物边界
- 批准号:
DP240102658 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Discovery Projects
Advanced Multiscale Biological Imaging using European Infrastructures
利用欧洲基础设施进行先进的多尺度生物成像
- 批准号:
EP/Y036654/1 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Marine Biological Association
2024 年开放获取区块奖 - 海洋生物学协会
- 批准号:
EP/Z532538/1 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Research Grant
NSF/BIO-DFG: Biological Fe-S intermediates in the synthesis of nitrogenase metalloclusters
NSF/BIO-DFG:固氮酶金属簇合成中的生物 Fe-S 中间体
- 批准号:
2335999 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
DESIGN: Driving Culture Change in a Federation of Biological Societies via Cohort-Based Early-Career Leaders
设计:通过基于队列的早期职业领袖推动生物协会联盟的文化变革
- 批准号:
2334679 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
Collaborative Research: The Interplay of Water Condensation and Fungal Growth on Biological Surfaces
合作研究:水凝结与生物表面真菌生长的相互作用
- 批准号:
2401507 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
REU Site: Modeling the Dynamics of Biological Systems
REU 网站:生物系统动力学建模
- 批准号:
2243955 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411529 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411530 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant
Collaborative Research: NSF-ANR MCB/PHY: Probing Heterogeneity of Biological Systems by Force Spectroscopy
合作研究:NSF-ANR MCB/PHY:通过力谱探测生物系统的异质性
- 批准号:
2412551 - 财政年份:2024
- 资助金额:
$ 3.41万 - 项目类别:
Standard Grant